Quantcast

Latest pharmaceutical industry Stories

2014-08-13 16:26:30

TORONTO, Aug. 13, 2014 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced its financial and operational results for the three and six months ended June 30, 2014. All financial references are in U.S. dollars unless otherwise noted. Financial Results...

2014-08-13 16:25:38

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug. 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that the Phase 3 clinical trial FOCUS (CarFilzOmib for AdvanCed Refractory MUltiple Myeloma European Study) did not meet its primary endpoint of improving overall survival (OS) (HR=0.975, 95 percent CI, 0.760, 1.249). The 315-patient, open-label study evaluated single-agent Kyprolis(®) (carfilzomib) for Injection...

2014-08-13 16:25:21

ReportsnReports.com offer Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges a market research report added to its store. DALLAS, Aug. 13, 2014 /PRNewswire-iReach/ -- The report on Pharmaceutical Industry in China provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government...

2014-08-13 08:29:58

Phase III Trial Is Alive And Well; "Hint Of Failure" A Complete Fabrication; No Interim Analysis of Efficacy Done; 55 Patients' Positive Data Independently Collected. BETHESDA, Md., Aug. 13, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today corrected ongoing false claims by Adam Feuerstein published on the TheStreet.com about the Company's Phase III trial of DCVax-L...

2014-08-12 23:10:34

A Rise In Lipitor Lawsuit Claims Jumped In Five Months With Filings That Contend Development Of Type 2 Diabetes After Taking The Cholesterol Lowing Medication, Notes Wright & Schulte LLC Columbus, OH (PRWEB) August 12, 2014 The harmful drug attorneys at Wright & Schulte LLC have learned through a Reuters analysis that Lipitor diabetes lawsuits filed against Pfizer Inc. have spiked over the past five months primarily due to all federally filed Lipitor lawsuit claims consolidated in...

2014-08-12 23:09:28

In support of the Alliance for Clinical Research Excellence and Safety (ACRES) global collaborative model, industry stakeholders have pledged more than $102M in technologies and services to transform the clinical research enterprise and accelerate medicines development, enhancing quality, safety and long-term industry sustainability. (PRWEB) August 12, 2014 Following the recent meeting of a multi-sector global stakeholder consultation on clinical research site-excellence, strategic allies...

2014-08-12 23:09:05

HOLLOWAY AMERICA will offer information about its pressure vessel design and custom fabrication of reactor vessels and other pressure tanks for pharmaceutical and biopharmaceutical processes. Springfield, MO (PRWEB) August 12, 2014 The pressure vessel design and custom fabrication company HOLLOWAY AMERICA today announced it will have an exhibit at the ISPE San Diego Chapter 22nd Annual Exhibit Show: Life Science Resource Fair on Thursday, August 14, 2014 at Green Acre Campus Pointe in San...

2014-08-12 16:28:07

SAN DIEGO, Aug. 12, 2014 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced operating results for the second quarter 2014. The company will host a conference call today to discuss financial results for the quarter and to provide an operational update for the first half of 2014. "We are pleased to have initiated our...

2014-08-12 16:28:04

LUTHERVILLE, Md., Aug. 12, 2014 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) - a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion lauded the latest National Precursor Log Exchange (NPLEx) results. NPLEx reported January through July results that were achieved by the real-time,...

2014-08-12 16:27:31

DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Biological drugs are typically derived from living cells and are used in the treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders....


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'